Welcome to Drug and Alcohol Treatment
| ||
Drug Treatment Crohn's Disease Article
This is a selection made from among articles on Drug Treatment Crohn's Disease. For a permanent link to this article, or to bookmark it for future reading, click here.
How to Abstain from Drugs
from: Though there are many preventive acts to not to abuse drugs, drug addictives number is increasing year by year. Once a person addicted to drugs, still there is a way to abstain him from abusing drugs. It is “Drug Addiction Treatment”.There are many reasons why a person would need to attend a drug rehabilitation program. A few of the many reasons are: the inability to control their drinking or drug use, alienating their friends and family, legal problems, severe depression and general unhappiness due to excessive drug or alcohol use.
A drug rehab is a place or program that an individual enters in order to treat a drug or alcohol addiction problem. Through therapy and education, Individual's are rehabilitated using various treatment methods that enable them to lead a productive and drug free life.
There are many addictive drugs, and drug rehabs for specific drugs can differ. Drug rehab also varies depending on the specific needs of the patient. There are many different types of drug rehab programs available: in patient, outpatient, residential, short-term, and long-term. The initial step of drug or alcohol addiction treatment is drug detoxification.
In general, the more treatment received the greater the results. Drug and alcohol abusers who remain in treatment longer than 3 months typically have greater success than those who receive less treatment. Addicted individuals who undergo medically assisted drug or alcohol detox to minimize the discomfort of withdrawal symptoms but do not receive any further treatment, perform about the same in terms of their drug or alcohol use as those who are never treated at all.
Over the last 25 years, studies have shown that drug rehab treatment is very effective in reducing or eliminating drug and alcohol intake. Researchers also have found that drug abusers who have been through a treatment program are more likely to have greater stability generally in all aspects of life i.e. family, work, accomplishing personal goals etc.
Abuse of Rx and OTC medications is on par or higher than the abuse of illegal drugs such as Ecstasy (8 percent), cocaine/crack (10 percent), methamphetamine (8 percent) and heroin (5 percent).
For some individuals drug addiction treatment does not succeed at eliminating their addiction. This can result from a number of aspects of the drug addiction treatment together with the individual’s own character and personality type.
In addition to the duration of treatment, the type of drug rehab facility is an important factor as well. There are many different treatment modalities: therapeutic communities or residential treatment centers, Twelve Step, Drug Treatment, Sober Living, Drug Counseling, Behavioral Therapy, Cognitive Therapy, Narconon, and many more. The importance of correctly Diagnosing the individual and selecting the appropriate type of treatment option should not be underestimated as this may be the difference between success and failure in the recovery process.
About Author
DrugTestStrips.com is an online store offering drug test kits and drug screening products in several formats including blood, urine and oral drug test kit. These drug test kits can be used discreetly for at home drug test or for random employee drug testing. Some of the popular products are marijuana drug test, breathalyzer and oral drug test.
Source: ArticleTrader.com
Drug Treatment Crohn's Disease Specific links
Drug Treatment Crohn's Disease News
IBD Meds Appear Safe in Pregnancy - MedPage Today
IBD Meds Appear Safe in Pregnancy MedPage Today After adjustment for disease activity, patients with Crohn's disease, who generally were not as sick as those with ulcerative colitis, had no increase in any complications. However, women with ulcerative colitis who had received both azathioprine plus ... |
Safe to Switch Thiopurines in IBD Patients - MedPage Today
Safe to Switch Thiopurines in IBD Patients MedPage Today In a single-center cohort of patients with ulcerative colitis or Crohn's disease, 60% of those who had stopped azathioprine because of adverse effects such as gastrointestinal toxicity and flu-like illness were able to tolerate mercaptopurine, ... |
A Stem-Cell-Based Drug Gets Approval in Canada - New York Times
 Proactive Investors UK | A Stem-Cell-Based Drug Gets Approval in Canada New York Times The company, Osiris Therapeutics of Columbia, Md., said Thursday that Canadian regulators had approved its drug Prochymal, to treat children suffering from graft-versus-host disease, a potentially deadly complication of bone marrow transplantation. Osiris Approved To Market Prochymal For Graft-Vs-Host Disease In Canada Osiris Shares Increase on Approval for Stem-Cell Therapy World's First Approved Stem Cell Drug; Osiris Receives Marketing Clearance ... |
Gaithersburg drug-maker signs deal for European market - Gazette.Net: Maryland Community News Online
Gaithersburg drug-maker signs deal for European market Gazette.Net: Maryland Community News Online This year, the commission focused on projects involving regenerative medicine, such as treatments for sickle cell anemia, schizophrenia, type 1 diabetes, nerve injury, Parkinson's disease, Crohn's disease, multiple sclerosis, heart disease, ... |
New Studies Confirm Value of Given Imaging's PillCam(R) SB in Managing ... - MarketWatch (press release)
New Studies Confirm Value of Given Imaging's PillCam(R) SB in Managing ... MarketWatch (press release) Depending on the severity, treatment options include nutritional supplements, drugs and surgery. There is currently no cure for the disease(4). Twenty percent of all cases of Crohn's disease affect children, appearing in children as young as seven ... |
New research identifies possible risk factors, treatments for bowel - Science Codex
New research identifies possible risk factors, treatments for bowel Science Codex Other research examines the effect of cutting-edge therapies on ulcerative colitis and Crohn's disease, collectively known as inflammatory bowel disease (IBD). Although incompletely understood, this is a complex disease in which many factors, ... |
Abbott's New Use for Top Drug Humira Delayed by US - Bloomberg
Abbott's New Use for Top Drug Humira Delayed by US Bloomberg About 500000 people in the US have the disease, according to the Crohn's & Colitis Foundation of America. The disease is treated with generic drugs that reduce inflammation or moderate the immune system. Patients who fail those treatments may be given ... |
ChemoCentryx Presents Data on CCX168, an Orally Administered Small Molecule ... - MarketWatch (press release)
ChemoCentryx Presents Data on CCX168, an Orally Administered Small Molecule ... MarketWatch (press release) ChemoCentryx's most advanced drug candidate, vercirnon (also known as Traficet-EN, CCX282 or GSK1605786), a specific CCR9 inhibitor, completed a multi-national clinical trial, called PROTECT-1, in patients with moderate-to-severe Crohn's disease, ... ChemoCentryx Announces Transfer of Existing Shares Between Current Stockholders |
Genes May Link Disparate Diseases - Wall Street Journal
Genes May Link Disparate Diseases Wall Street Journal It also could aid drug development. By figuring out which proteins are most critical to the normal functioning of the body, pharmaceutical companies could target those key proteins to treat disease. In some cases, drug companies may want to avoid ... The genetic links between different diseases |
Digestive Disease Week Presentations Support Therapeutic Potential for Gattex ... - MarketWatch (press release)
Digestive Disease Week Presentations Support Therapeutic Potential for Gattex ... MarketWatch (press release) "Gattex may represent an entirely new approach for treating adult short bowel syndrome and these presentations from multiple clinical studies reinforce our belief in the drug's therapeutic potential," said Roger Garceau, MD, senior vice president and ... |